Activity 1: Monitor twice yearly antimalarial availability, price and volumes and retailer perceptions
and knowledge of all anti-malarial drugs.
- Project-level study design
- Eight country-level study designs
- Quantitative tables
- Report
Activity 2: USP to monitor antimalarial drug quality at the point of sale/service.
- Documentation of stakeholder involvement per country
- Documentation of the quality control procedure per country.
- Implementation of the first round of screening, verification, and field and laboratory
testing.
|